Pacira Escapes Shareholder Suit Over Drug Marketing
A New Jersey federal judge on Wednesday dismissed a shareholder suit against Pacira Pharmaceuticals Inc., finding that while the company had misbranded its anesthetic Exparel, it told investors that it planned...To view the full article, register now.
Already a subscriber? Click here to view full article